{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:54:59Z","timestamp":1710953699570},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T00:00:00Z","timestamp":1301961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1038\/nrclinonc.2011.51","type":"journal-article","created":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T18:20:29Z","timestamp":1302027629000},"page":"321-322","source":"Crossref","is-referenced-by-count":8,"title":["Relapsed and refractory PTCL\u2014into the therapeutic abyss"],"prefix":"10.1038","volume":"8","author":[{"given":"Francine","family":"Foss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,5]]},"reference":[{"key":"BFnrclinonc201151_CR1","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose, J. et al. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol. 26, 4124\u20134130 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc201151_CR2","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","volume":"116","author":"N Schmitz","year":"2010","unstructured":"Schmitz, N. et al. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood 116, 3418\u20133425 (2010).","journal-title":"Blood"},{"issue":"15 Suppl.","key":"BFnrclinonc201151_CR3","doi-asserted-by":"crossref","first-page":"a8554","DOI":"10.1200\/jco.2009.27.15_suppl.8554","volume":"27","author":"A Delmer","year":"2009","unstructured":"Delmer, A. et al. A phase II study of bortezomib in combination with intensified CHOP-like regimen (ACVBP) in patients with previously untreated T-cell lymphoma: results of the GELA LNH05\u201301T trial [abstract]. J. Clin. Oncol. 27 (15 Suppl.), a8554 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc201151_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","volume":"27","author":"P Reimer","year":"2009","unstructured":"Reimer, P. et al. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J. Clin. Oncol. 27 106\u2013113 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc201151_CR5","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J Rodr\u00edguez","year":"2007","unstructured":"Rodr\u00edguez, J. et al. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann. Oncol. 18, 652\u2013657 (2007).","journal-title":"Ann. Oncol."},{"issue":"Suppl. 2","key":"BFnrclinonc201151_CR6","first-page":"a437","volume":"94","author":"F D'Amore","year":"2009","unstructured":"D'Amore, F. et al. Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral T-cell lymphomas (PTCLs)\u2014overall and subtype-specific results of a phase II study from the Nordic Lymphoma Group. Haematologica 94 (Suppl. 2), a437 (2009).","journal-title":"Haematologica"},{"key":"BFnrclinonc201151_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","volume":"29","author":"OA O'Connor","year":"2011","unstructured":"O'Connor, O. A. et al. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J. Clin. Oncol. 29, 1182\u20131189 (2011).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc201151_CR8","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1200\/JCO.2008.20.8470","volume":"27","author":"OA O'Connor","year":"2009","unstructured":"O'Connor, O. A. et al. Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies. J. Clin. Oncol. 27, 4357\u20134364 (2009).","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"BFnrclinonc201151_CR9","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","volume":"117","author":"R. L. Piekarz","year":"2011","unstructured":"Piekarz, R. L. et al. Phase II trial of romidepsin in patients with peripheral T-cell lymphoma. Blood doi:10.1182\/blood-2010-10-312603.","journal-title":"Blood"},{"key":"BFnrclinonc201151_CR10","doi-asserted-by":"publisher","first-page":"a114","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier, B. et al. Final results from a pivotal, multicenter, international, open-label, phase 2 study of romidepsin in progressive or relapsed peripheral T-cell lymphoma (PTCL) following prior systemic therapy [abstract]. Blood 116, a114 (2010).","journal-title":"Blood"}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2011.51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2011.51","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2011.51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:19:00Z","timestamp":1684466340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2011.51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,5]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["BFnrclinonc201151"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2011.51","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,5]]}}}